Table 5 The detailed descriptions of the mRS score before treatment, the mRS score after treatment and the number of lesions on 18F-FDG PET of AE patients

1

NMDAR

Female

36

4

3

8

2

NMDAR

Male

34

4

3

6

3

LGI1

Female

64

3

2

3

4

LGI1

Male

54

1

0

3

5

LGI1

Female

40

1

0

3

6

LGI1

Male

54

4

1

1

7

LGI1

Male

55

3

1

1

8

GABABR

Male

66

4

6

2

9

GABABR

Female

56

3

6

4

10

GABABR

Male

64

4

2

2

11

GABABR

Male

57

1

5

2

12

HU

Female

55

3

6

6

13

HU

Female

67

4

6

0

14

HU

Male

77

4

6

5

15

HU

Female

60

3

2

1

16

SOX1 and HU

Female

51

4

2

4

17

SOX1 and HU

Female

63

4

6

4

18

HU and RI

Female

66

3

1

1

19

GAD65-Ab + 

Female

64

3

1

1

20

GAD65-Ab + 

Female

55

2

1

4

21

PNMA2 + /Ma2/Ta

Female

48

5

3

5

22

Amphiphysin

Male

63

3

1

3